30 ILCS 785/ Inclusion of Women and Minorities in Clinical Research Act.

Updating the database of the Illinois Compiled Statutes (ILCS) is an ongoing process. Recent laws may not yet be included in the ILCS database, but they are found on this site as Public Acts soon after they become law. For information concerning the relationship between statutes and Public Acts, refer to the Guide.

Because the statute database is maintained primarily for legislative drafting purposes, statutory changes are sometimes included in the statute database before they take effect. If the source note at the end of a Section of the statutes includes a Public Act that has not yet taken effect, the version of the law that is currently in effect may have already been removed from the database and you should refer to that Public Act to see the changes made to the current law.

30 ILCS 785/1

(30 ILCS 785/1)

Sec. 1.

Short title.

This Act may be cited as the Inclusion of Women and
Minorities in Clinical Research Act.

(Source: P.A. 93-514, eff. 1-1-04.)

30 ILCS 785/5

(30 ILCS 785/5)

Sec. 5. Definitions. In this Act:

"Grantee" means any qualified public, private, or not-for-profit agency or
individual, including, but not limited to, a college, university, hospital,
laboratory,
research institution, local health department, voluntary health agency, health
maintenance
organization, corporation, student, fellow, or entrepreneur, conducting
clinical research
using State funds. A grantee may also be a corporation that is headquartered in
Illinois
and that conducts research using State funds.

"Minority group" means a group that is a readily identifiable subset of the U.S. population that is distinguished by racial, ethnic, or cultural heritage and that is made up of persons who are any of the following:

(1) American Indian or Alaska Native (a person having

origins in any of the original peoples of North and South America, including Central America, and who maintains tribal affiliation or community attachment).

(2) Asian (a person having origins in any of the

original peoples of the Far East, Southeast Asia, or the Indian subcontinent, including, but not limited to, Cambodia, China, India, Japan, Korea, Malaysia, Pakistan, the Philippine Islands, Thailand, and Vietnam).

(3) Black or African American (a person having

origins in any of the black racial groups of Africa).

(4) Hispanic or Latino (a person of Cuban, Mexican,

Puerto Rican, South or Central American, or other Spanish culture or origin, regardless of race).

(5) Native Hawaiian or Other Pacific Islander (a

person having origins in any of the original peoples of Hawaii, Guam, Samoa, or other Pacific Islands).

"Project of clinical research" includes a clinical trial.

(Source: P.A. 102-465, eff. 1-1-22.)

30 ILCS 785/10

(30 ILCS 785/10)

Sec. 10. Inclusion of women and minorities.

Except as provided in Section
15
or 30, in conducting or supporting a project of clinical research, a grantee
must do all of
the following:

(1) Ensure that women, including, but not limited to,

women over the age of 40 years, are included as subjects in each research project.

(2) Ensure that members of minority groups are

included as subjects in each research project.

(3) Conduct or support outreach programs for the

recruitment of women and members of minority groups as subjects in projects of clinical research.

(4) Comply with the National Institutes of Health

Guidelines on the Inclusion of Women and Minorities in Clinical Research.

(Source: P.A. 93-514, eff. 1-1-04; 93-787, eff. 1-1-05.)

30 ILCS 785/15

(30 ILCS 785/15)

Sec. 15.

Exceptions.

The requirements established in Sections 10 and 25
regarding women and members of minority groups do not apply to a project of
clinical
research if the inclusion of women and members of minority groups as subjects
in the
project is inappropriate because of either of the following:

(1) The health and safety of the subjects.

(2) The purpose of the research.

(Source: P.A. 93-514, eff. 1-1-04.)

30 ILCS 785/20

(30 ILCS 785/20)

Sec. 20.

Manner of conducting trial.

In a clinical trial in which women
or
members of minority groups will be included as subjects as required under
Section 10, a
grantee must ensure that the trial is designed and carried out in a manner
sufficient to
provide for a valid analysis of whether the variables being studied in the
trial affect
women or members of minority groups, as the case may be, differently than other
subjects in the trial.

(Source: P.A. 93-514, eff. 1-1-04.)

30 ILCS 785/25

(30 ILCS 785/25)

Sec. 25.

Grantee bound by terms of Act.

In any grant, or in any contract
by
a
grantee under a grant, the grantee or contracting party must acknowledge, agree
to, and be
bound by the terms of this Act.

(Source: P.A. 93-514, eff. 1-1-04.)

30 ILCS 785/30

(30 ILCS 785/30)

Sec. 30.

Grantee's compliance with 2000 National Institutes of Health
guidelines. If a grantee is in compliance with the 2000 National Institutes of
Health
guidelines, the grantee shall be deemed to be in compliance with this Act.

(Source: P.A. 93-514, eff. 1-1-04.)